In this study, we found that CML stem cells effectively employ dipeptide uptake mediated by Slc15A2 activity to guarantee an alternative nutrient supply and maintain LT survival in vivo. Here, SLC15A2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.